Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
Claus G Roehrborn1, Raymond C Rosen21Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA; 2New England Research Institutes, Watertown, MA, USAAbstract: Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) are common in ag...
Saved in:
Main Authors: | Claus G Roehrborn, Raymond C Rosen |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/3c62a8f7c5e74916b124a7f817463211 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
by: Zhang LT, et al.
Published: (2015) -
The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
by: Yang L, et al.
Published: (2021) -
Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
by: Wang XY, et al.
Published: (2016) -
Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system
by: McNicholas TA
Published: (2016) -
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial
by: Amr Fawzi, et al.
Published: (2017)